Session ID: 1011 June 16, Patti Varley, ARNP, MN, CS APNA 10 th Annual Clinical Psychopharmacology aco ogy Institute June 14-17, 2012 Reston, VA
|
|
|
- Clarence Cole
- 5 years ago
- Views:
Transcription
1 Child and Adolescent Psychopharm Considerations Patti Varley, ARNP, MN, CS APNA 10 th Annual Clinical Psychopharmacology aco ogy Institute tute June 14-17, 2012 Reston, VA This speaker has no conflict of interest to disclose but will discuss off label use of medication. Patti Varley, ARNP, MN, CS 1
2 DOMAINS BIOLOGICAL PSYCHOLOGICAL SOCIOLOGICAL BIOLOGICAL Patti Varley, ARNP, MN, CS 2
3 Review of Brain Maturation and Neurodevelopment Complex process involving : Neuronal migration Brain volume Specialization of areas of the brain White matter/myelination completion Pruning and planned cell death Dendritic Arborization This elegant complicated process is not completed until end of adolescence or even later Patti Varley, ARNP, MN, CS 3
4 Effects Over Time of Brain Development of Medications Unknown effects on neurotransmitters over time on dopamine, serotonin, and noradrenergic receptors in a developing organism Role of Development in Responses to Medications Patti Varley, ARNP, MN, CS 4
5 While drug doses are empirically determined, there are differences in pharmacokinetics in children vs. adults Children and Adolescents Require Higher Weight-Adjusted Dose vs. Adults A result of shorter half-lives owing to increased metabolism and excretion in youth Patti Varley, ARNP, MN, CS 5
6 Absorption Different in Children vs. Adults Children Less acid in stomach Less microflora in the gut gut transit times Distribution of Drugs Children Children More fat stores up to age one year and then decreases up to puberty Less body fat than adults More extracellular water This results, for example, in lower lithium levels in children on the same mg/kg dosage Patti Varley, ARNP, MN, CS 6
7 Genomics Genetics and family history Scientists believe that many mental disorders result from the complex interplay of multiple genes with diverse environmental factors. Family studies, often with identical twins who share the same genes, have provided evidence of genetic contributions to depression, bipolar disorder, schizophrenia, autism, and other mental disorders. Even for those with genetic risk, however, environmental factors can play a significant role in whether or not a person develops a disorder, or the severity of an illness. Genomics CDC Activities CDC's Office of Public Health Genomics funds the Evaluation of Genomic Applications in Practice and Prevention (EGAPP ) Working Group, an independent, multidisciplinary, non-federal panel that is developing methods for systematic, evidence-based evaluation of genetic tests and genomics applications that are in transition from research to practice. Patti Varley, ARNP, MN, CS 7
8 Pharmacogenetics Psychological Patti Varley, ARNP, MN, CS 8
9 WHO ARE WE TREATING AND WHY ARE WE TREATING? Essential that psychotropic medications address primary and significant ifi psychiatric i problems in children Not treating parents Not treating schools Patti Varley, ARNP, MN, CS 9
10 Children and adolescents never present on their own Differences in reports of problems in child patient, parent, and the teacher. These differences need to be reconciled. For example, more disruptive behaviors are reported by parents and teachers. Mood and anxiety symptoms are more often reported by children. Specifically, suicidal ideation is more often reported by children and adolescents. CONSENT, ASSENT, AND PARTNERSHIP Patti Varley, ARNP, MN, CS 10
11 Consent for mental health care required in children at different ages depending on state law Should also in younger children obtain assent Integration of Data from Multiple Informants regarding Target Symptoms and Side Effects Patient Parents Mom Dad Guardian Teachers Others Patti Varley, ARNP, MN, CS 11
12 Role of Caregivers and the Meaning of Medication Psychopharmacology in Context of Other Treatments When given meds and psychotherapy, even when better response with psychotherapy, kids tend to think meds cause improvement Patti Varley, ARNP, MN, CS 12
13 COMPLIANCE ISSUES AND A DEVELOPMENTAL REFERENCE Major compliance issues in children and adolescents Adherence Issues What is the difference????? Need to explain costs and benefits to a child in a developmentally sensitive manner Patti Varley, ARNP, MN, CS 13
14 SOCIOLOGICAL NORMAL DISORDER Presentation in advertising Are problems treated that don t need treatment that cause side effects that require more treatment Patti Varley, ARNP, MN, CS 14
15 ARE WE OVER MEDICATING CHILDREN IN THE UNITED STATES? Rx Patti Varley, ARNP, MN, CS 15
16 Psychotropic Medication in Youth % in US 2.9% in the Netherlands 2.0% in Germany Zito, 2008 INCREASED RATES OF PSYCHIATRIC DISORDER AND PSYCHOTROPIC MEDICATION PRESCRIPTION IN FOSTER CHILDREN Patti Varley, ARNP, MN, CS 16
17 HOW LONG DO WE TREAT CHILD AND ADOLESCENT PSYCHIATRIC PATIENTS WITH MEDICATION? EFFECTS OF PHARMACEUTICAL INDUSTRY Patti Varley, ARNP, MN, CS 17
18 Direct-to-consumer advertising - the promotion of prescription drugs through newspaper, magazine, television and internet marketing - along with brochures, videos given to patients from medical providers offices US and? DIRECT TO CONSUMER DIRECT TO CONSUMER ADVERTISING Patti Varley, ARNP, MN, CS 18
19 Eid Evidence Based Practice Studies in Child and Adolescent Psychopharmacology Pharmaceutical company sponsored studies.. RUPP TADS PATS MTA TEOSS CAMS TORDIA AUTISM STUDY Patti Varley, ARNP, MN, CS 19
20 Business ethics, whose main concerns are profit and legal operation, collide with medical ethics, which are directed to the patient's benefit, when academic research is dependent on industry money. We must formulate and enforce a new set of rules to restore doctors' credibility Research on drug studies repeatedly shows that drug trial results are tilted toward a positive description of the drug's effects when the research is funded by a drug company rather than the government or an independent agency Patti Varley, ARNP, MN, CS 20
21 Pediatric Psychopharmacology Increased Public Concern Questions of over-medication and over-diagnosis Since 2003, FDA has issued separate warnings regarding Antidepressants (suicidality) Atypical antipsychotics (metabolic problems) Stimulants (potential for sudden death and cardiovascular problems) Atomoxetine (suicidality) Antiepileptics (suicidality) Patti Varley, ARNP, MN, CS 21
22 Orphans of Pharmacological Research Off label use Over-dosing Under-dosing Efficacy Safety Research Most medication used to treat children and adolescents, especially young children are used off-label FDA and NIH are developing and encouraging new research approaches Patti Varley, ARNP, MN, CS 22
23 COMPLIMENTARY MEDICINE More and more common. Polypharmacy Patti Varley, ARNP, MN, CS 23
24 Side Effects: Clinical Experience vs. Textbook Patti Varley, ARNP, MN, CS 24
25 Inside of me there is creativity running through my body like a river, flowing into a lake. Inside of me is a purring cat happy to be petted, playful and curious. Inside of me is a castle on a hill surrounded by trees. Sometimes at war with an army of knights, sometimes in peace with the enemy. Inside of me a tree grows unharmed, branches reaching out as far as they can, roots growing down to good soil. Inside of me a key waits for someone to unlock the chest and free the treasure. Mike Uhrich h Grade 6 Patti Varley, ARNP, MN, CS 25
26 Book Child and Adolescent Behavioral Health: A Resource for Advanced Practice Psychiatric and Primary Care Practitioners in Nursing [Paperback] Edilma L. Yearwood (Editor), Geraldine S. Pearson (Editor), Jamesetta A. Newland (Editor) Wiley-Blackwell, 2012 References Wiley-Blackwell (2010, April 20). Psychotropic medications overprescribed to children, study suggests. ScienceDaily. Retrieved June 23, 2010, from /releases/2010/04/ htm Vitiello, B. Research in child and adolescent psychopharmacology: recent accomplishments and new challenges Psychopharmacology (Berl) 2007; 191:5-13 Patti Varley, ARNP, MN, CS 26
27 Favorite Resources Journals -American Academy of Child and Adolescent Psychiatry y (orange journal) -Journal of Child and Adolescent Psychopharmacology Newsletters -The Brown University: Child & Adolescent Psychopharmacology UPDATE -Child & Adolescent PSYCHIATRY ALERTS -Child& Adolescent Psychopharmacology News -NeuroPsychiatry Reviews Patti Varley, ARNP, MN, CS 27
BIOLOGICAL PSYCHOLOGICAL SOCIOLOGICAL. Session ID: 1011 June 16, Patti Varley, ARNP, MN, CS 1. This speaker has no conflict of interest to
Child and Adolescent Psychopharm Considerations Patti Varley, ARNP, MN, CS APNA 10 th Annual Clinical Psychopharmacology Institute June 14-17, 2012 Reston, VA This speaker has no conflict of interest to
Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology
Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology Objective: To discuss basic principles of psychopharmacology in children and adolescents. Pharmacokinetics:
Child and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014
Child and Adolescent Psychiatry Trends ADAMHS Board - 28 Oct 2014 Current Need for Child and Adolescent Psychiatrists There are currently approximately 7400 Child and Adolescent Psychiatrists in Practice
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
Medication Module. On the Path to Recovery: Medication, Mental Health Treatment, and the Transition to Adulthood November 4, 2011
Medication Module On the Path to Recovery: Medication, Mental Health Treatment, and the Transition to Adulthood November 4, 2011 Webinar presented by Ajit Jetmalani, Tally Moses, and Martin Rafferty. 2
MODEL PSYCHOPHARMACOLOGY CURRICULUM
Third Edition MODEL PSYCHOPHARMACOLOGY CURRICULUM For Psychiatric Residency Programs, Training Directors and Teachers of Psychopharmacology VOLUME I By A Committee of the American Society of Clinical Psychopharmacology
Taking Care: Child and Youth Mental Health TREATMENT OPTIONS
Taking Care: Child and Youth Mental Health TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS With appropriate treatment, more than 80% of people with depression get full relief from their symptoms
Pediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
TALKING TO PATIENTS AND FAMILIES ABOUT MEDICATIONS: IMPROVING QUALITY OF CARE AND REDUCING PROFESSIONAL LIABILITY RISK WHEN PRESCRIBING FOR CHILDREN
A benefit of participation in TALKING TO PATIENTS AND FAMILIES ABOUT MEDICATIONS: IMPROVING QUALITY OF CARE AND REDUCING PROFESSIONAL LIABILITY RISK WHEN PRESCRIBING FOR CHILDREN Introduction This article
Trends in the Prescribing of Psychotropic Medications to Preschoolers Original Contribution
1 Trends in the Prescribing of Psychotropic Medications to Preschoolers Original Contribution JAMA, Vol. 283 No. 8, February 23, 2000, pp. 1025-1030. Julie Magno Zito, PhD; Daniel J. Safer, MD; Susan dosreis,
Adult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160
Adult Mental Health Services Comparison Create and maintain a document in an easily accessible location on such health carrier's Internet web site that (i) (ii) compares each aspect of such clinical review
EARLY ONSET SCHIZOPHRENIA
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington
Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013
A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote
5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
.Wolters Kluwer Health
Ovid: Psychotropic Drug Use in Very Young Children. Page 1 of3.wolters Kluwer Health Full Text OvidSP Main Search Page I ('/ Ask a Librarian I Displi Knowledge Base I Help I Logoff Save Article Text Email
Psychiatric Care. Course Goals
Course Goals Goals 1. Develop skills, knowledge & attitudes necessary to perform a psychiatric assessment consistent with level of training. 2. Develop skills to help patients identify current major concern(s),
INFORMED CONSENT FOR PSYCHOTROPIC MEDICATION
INFORMED CONSENT FOR PSYCHOTROPIC MEDICATION Richard LaVallo Attorney at Law Disability Rights Texas October 25, 2013 Why Does Informed Consent Matter? Under the common law, a physician has a duty to make
New Jersey Department of Children and Families Policy Manual. Date: Chapter: A Health Services Subchapter: 1 Health Services
New Jersey Department of Children and Families Policy Manual Manual: CP&P Child Protection and Permanency Effective Volume: V Health Date: Chapter: A Health Services 1-11-2017 Subchapter: 1 Health Services
D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.
Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor
Application of EventFlow to Model the Complexity and Continuity of Antipsychotic Use Among Youth
Application of EventFlow to Model the Complexity and Continuity of Antipsychotic Use Among Youth Susan dosreis, 1 Wendy Camelo Castillo, 1 James Gardner, 1 Ming-Hui Tai, 1,2 1 Department of Pharmaceutical
Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care
Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care Appendices Appendix A Psych Meds Data Indicators by State The data elements being collected by the
Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline
Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced
Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives
Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy
Table of Contents. 1.0 Policy Statement...1
Division of Medical Assistance General Clinical Policy No. A-6 Table of Contents 1.0 Policy Statement...1 2.0 Policy Guidelines...1 2.1 Eligible Recipients...1 2.1.1 General Provisions...1 2.1.2 EPSDT
Practical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More
Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
NATIONAL ACADEMY OF NEUROPSYCHOLOGY
NATIONAL ACADEMY OF NEUROPSYCHOLOGY CLINICAL PSYCHOPHARMACOLOGY SYLLABUS OVERVIEW The goal of this CE is to provide participants with our current understanding of the molecular sites and mechanisms of
CHAPTER 2 EVALUATING NUTRITION INFORMATION OVERVIEW
CHAPTER 2 EVALUATING NUTRITION INFORMATION OVERVIEW Chapter 2 focuses on the generation and dissemination of nutrition knowledge. The scientific method is presented as the basis for nutrition research,
Mending the Mind: treatment of the severely mentally ill
Mending the Mind: treatment of the severely mentally ill First, the bad news Mental Illness Prevalence: putting things in perspective --More than 54 million Americans have a mental disorder in any given
Bipolar disorder is also sometimes called manic depression, bipolar affective disorder or bipolar mood disorder.
Bipolar Disorder What is bipolar disorder? Bipolar disorder is also sometimes called manic depression, bipolar affective disorder or bipolar mood disorder. Bipolar disorder is an illness in which there
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components
Adherence in A Schizophrenia:
Understanding and Diagnosing Bipolar Disorder Treatment Promoting for Bipolar Treatment Disorder Adherence in A Schizophrenia: Resource for Providers Engagement Strategies for Health Care Providers, Case
GOALS FOR THE PSCYHIATRY CLERKSHIP
GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form Please fax form to 617.673.0988 or mail to Tufts Health Plan, 705 Mount Auburn Street, Watertown, MA 02472, Attn:
Aggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
Tobacco Dependence Treatment From Neurobiology through Public Policy
Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National
Psychiatry Under the Influence: Institutional Corruption, Social Injury and Prescriptions for Reform. Robert Whitaker August 2016
Psychiatry Under the Influence: Institutional Corruption, Social Injury and Prescriptions for Reform Robert Whitaker August 2016 DSM III was the book that changed everything. Jeffrey Lieberman American
Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines
Non-Formulary Behavioral Health Medications ADHD medications for children under The patient must have a diagnosis for which the requested medication is: o Approved based on FDA indication and limits; OR
Explain to patients and families the meaning and ramifications of FDA warnings regarding antidepressants. Appropriately monitor patients on
Antidepressants in Children and Adolescents: The Good, The Bad & The Ugly Raymond C. Love, Pharm.D., BCPP, FASHP Associate Dean and Professor, Pharmacy Practice & Science University of Maryland, School
HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.
HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided
2. You must remain available until at least 5:00PM each day unless approved by the Attending and Resident.
LECTURES AND MEETINGS: Requirements: 1. You are expected to attend all scheduled meetings, rounds, and case conferences conducted at the clinical sites to which you are assigned. 2. You must remain available
Medication Information for Parents and Teachers
Medication Information for Parents and Teachers General Information About Medication Gabapentin Neurontin, Gralise, Gralise Starter Each child and adolescent is different. No one has exactly the same combination
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
11/12/2017. How effective are treatments of psychiatric disorders in children and adolescents?
How effective are treatments of psychiatric disorders in children and adolescents? Benedetto Vitiello, M.D. Pavia, November 22, 2017 1 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent
Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct Disorders. Prof.
Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct s Prof. Daniel Kaplin College of Staten Island One of the new chapters in the Diagnostic and Statistical
Columbia University TeenScreen Program. The Carmel Hill Center at the Division of Child & Adolescent Psychiatry Columbia University
Columbia University TeenScreen Program The Carmel Hill Center at the Division of Child & Adolescent Psychiatry Columbia University 1 Overview Overview of TeenScreen Program Links Between Mental Illness
Antidepressants for treatment of depression.
JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic
European Network for Hyperkinetic Disorders EUNETHYDIS
European Network for Hyperkinetic Disorders EUNETHYDIS What can networks offer? Dave Coghill University of Dundee EUNETHYDIS Founded 22 years ago to facilitate collaborative research into the causes and
H. R To prohibit the use of Federal funds for any universal or mandatory mental health screening program. IN THE HOUSE OF REPRESENTATIVES
I TH CONGRESS D SESSION H. R. To prohibit the use of Federal funds for any universal or mandatory mental health screening program. IN THE HOUSE OF REPRESENTATIVES OCTOBER, 00 Mr. PAUL introduced the following
Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology
Contemporary Psychiatric-Mental Health Nursing Chapter 7 The Science of Psychopharmacology Psychopharmacology A primary treatment mode of psychiatric-mental health nursing care Psychopharmacology - continued
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
Life Care Plan. Kobe Williams. Projected Evaluations. Per Unit. Per Year
Projected Evaluations Rehabilitation Long-Term Needs Assessment 4 8/16/01 21 2018 3 X Only Assess Handicapping Conditions 1 X Already accomplished as of 4/19/01 evaluation; reevaluations recommended at
Illuminating the Black Box: Antidepressants, Youth and Suicide
Illuminating the Black Box: Antidepressants, Youth and Suicide David H. Rubin, M.D. Executive Director, MGH Psychiatry Academy Director, Postgraduate Medical Education Director, Child and Adolescent Psychiatry
Medications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
Increasing Use of Psychotropics
A Critical Curriculum on Psychotropic Medications A Critical Curriculum on Psychotropic Medications Principal Investigator: David Cohen, Ph.D. Professional Consultants: David O. Antonuccio, Ph.D. (psychology)
TRAINING PSYCHIATRISTS TO THINK LIKE PHARMACOLOGISTS: INTRODUCTION (2015 version) Jose de Leon, MD 04/20/16
TRAINING PSYCHIATRISTS TO THINK LIKE PHARMACOLOGISTS: INTRODUCTION (2015 version) Jose de Leon, MD 04/20/16 Dr. de Leon is affiliated with the University of Kentucky Department of Psychiatry and Eastern
Psychiatric Medications for Foster Youth: what we know and what we don t
Psychiatric Medications for Foster Youth: what we know and what we don t Implications for Child Welfare Practice Christopher Bellonci, M.D. Tufts University School of Medicine cbellonci@tuftsmedicalcenter.org
The Essential Guide to Lithium Treatment
The Essential Guide to Lithium Treatment Michael Bauer Michael Gitlin The Essential Guide to Lithium Treatment Michael Bauer Technische Universtät Dresden University Hospital Carl Gustav Carus Dresden
Improving Mental Health Care: A Case Study
Improving Mental Health Care: A Case Study Why Improve Mental Health Care? Because the prevalence and costs of mental health problems are increasing in America despite the high prescribing of psychotropic
^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs
^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs wm, ROBERT M.JULIEN M.D.. PH.D. Claire D. Advokat, Ph.D. Louisiana State University and Joseph
Position Statement A Response to CCHR s Psychotropic Drugging of Florida s Medicaid Children
Position Statement A Response to CCHR s Psychotropic Drugging of Florida s Medicaid Children In 2006, the Citizens Commission on Human Rights (CCHR) developed and distributed via the internet a white paper
ATOMOXETINE. THERAPEUTICS Brands Strattera see index for additional brand names. Generic? Yes
ATOMOXETINE THERAPEUTICS Brands Strattera see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: norepinephrine reuptake inhibitor (N-RI) Selective norepinephrine reuptake
American Psychiatric Nurses Association
Francis J. McMahon International Society of Psychiatric Genetics Johns Hopkins University School of Medicine Dept. of Psychiatry Human Genetics Branch, National Institute of Mental Health* * views expressed
CONTROVERSIES AND NEW DIRECTIONS
BIPOLAR Introduction DISORDER IN CHILDHOOD AND EARLY ADOLESCENCE Introduction MELISSA P. D ELBELLO, DAVID AXELSON, and BARBARA GELLER CONTROVERSIES AND NEW DIRECTIONS Although the existence and diagnostic
Course Title: 2012 Psychiatry CME To Go Audio Lecture Series
American Physician Institute for Advanced Professional Studies, LLC Course Title: 2012 Psychiatry CME To Go Audio Lecture Series Intended Audience: Psychiatrists CME Accreditation and Designation Statement
Follows all national minimum standards, guidelines and legislation and written to meet the skill set laid out by Skills For Care.
Care of Medicines Foundation Module The course is aimed at care home workers and covers the What is a drug? What is medicine? Legislation and medication Journey of a medicine Legal categories of medicine
Things You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
Major Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
Printing: Psychiatric Drugging of Infants and Toddlers in the US - Part I
OpEdNews Page 1 of 5 Original Content at http://www.opednews.com/articles/psychiatric-drugging-of-in-by-evelyn-pringle-100419-821.html April 19, 2010 Psychiatric Drugging of Infants and Toddlers in the
11 th Annual Pacer Symposium on Children s Mental Health
11 th Annual Pacer Symposium on Children s Mental Health DATE: AUGUST 9, 2016 PLACE: MINNEAPOLIS CONVENTION CENTER PRESENTERS: DR. RICHARD PETERSON & DR. BARRY GARFINKEL MY CHILD S FIRST VISIT WITH A CHILD
Disclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
Depression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
2016 ADHD Conference Speaker Biographies
2016 ADHD Conference Speaker Biographies Dr. Rosemary Tannock, PhD Rosemary Tannock is now Professor Emerita at the University of Toronto and continues as a Senior Scientist at the Hospital for Sick Children
Manual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
Scientific Panel MindFreedom Support Coalition International 454 Willamette, Suite 216 PO Box Eugene, OR USA
Scientific Panel MindFreedom Support Coalition International 454 Willamette, Suite 216 PO Box 11284 Eugene, OR 97440-3484 USA 20 September 2004 Cathryn M. Clary, MD, MBA, Vice President Psychiatry, Neurology,
DEPARTMENT OF PSYCHIATRY. Newsletter
DEPARTMENT OF PSYCHIATRY Office of the Chair - Week of March 4-8, 2013 Website: http://www.hsc.usf.edu/psych/ Newsletter Upcoming Grand Rounds Presentation The Morsani Center, Rooms 1013 A and B: Thursday,
CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
Diagnosis & Assessment in Pediatric Psychopharmacology
Diagnosis & Assessment in Pediatric Psychopharmacology Joseph Biederman, MD Professor of Psychiatry Harvard Medical School Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult
Current Research on the Effective Treatment of. Attention-Deficit/Hyperactivity Disorder. Carolyn Micheli
ADHD Treatment 1 RUNNING HEAD: ADHD Treatment Current Research on the Effective Treatment of Attention-Deficit/Hyperactivity Disorder Carolyn Micheli ADHD Treatment 2 Abstract This paper will explore Attention-Deficit/Hyperactivity
ATOMOXETINE. THERAPEUTICS Brands Strattera see index for additional brand names. Generic? Yes
ATOMOXETINE THERAPEUTICS Brands Strattera see index for additional brand names Generic? Yes Class Selective norepinephrine reuptake inhibitor (NRI) Commonly Prescribed For (bold for FDA approved) Attention
Major Depressive Disorder Websites Reviewed by Felisha Lotspeich
Major Depressive Disorder Websites Reviewed by Felisha Lotspeich Major depression. (2010). https://health.google.com/health/ref/major+depression This Website gives basic information about major depressive
Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
Psychotropic Medication
FOM 802-1 1 of 10 OVERVIEW The use of psychotropic medication as part of a child s comprehensive mental health treatment plan may be beneficial and should include consideration of all alternative interventions.
We seek to impact individuals with Autism Spectrum Disorders in future by serving families and professionals in Central Kentucky.
Advocates for Autism Awareness Sample Advocates for Autism Awareness is a group of families providing hope and support to one another; striving to build partnerships between families & professionals; and
Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
Medicating Children:! Science, Commerce, and Long-Term Outcomes. Robert Whitaker September 2016
Medicating Children: Science, Commerce, and Long-Term Outcomes Robert Whitaker September 2016 The Origins of the Medical Model DSM III was the book that changed everything. Jeffrey Lieberman American Psychiatric
Disclosures. Learning Objectives. Psychopharmacology of Pediatric Anxiety and Depression 5/4/2017
Psychopharmacology of Pediatric Anxiety and Depression Susan Sharp, DO Clinical Assistant Professor of Child and Adolescent Psychiatry Kansas University Medical Center The Children's Mercy Hospital, 2017
Antipsychotic Prior Authorization Request
Antipsychotic Prior Authorization Request Commonwealth of Massachusetts MassHealth Drug Utilization Review Program P.O. Box 2586, Worcester, MA 01613-2586 Fax: 1-877-208-7428 Phone: 1-800-745-7318 MassHealth
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
ABOUT ADHD IN PRESCHOOL CHILDREN
Press Release www.shire.com Shire Agrees to FDA Request to Conduct Clinical Trials Investigating the Potential Use of Vyvanse (lisdexamfetamine dimesylate) in Preschool-Age Children with ADHD Lexington,
Behavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
Orientation for New Child and Adolescent Psychiatry Residents: Module Two - Assessment
Orientation for New Child and Adolescent Psychiatry Residents: Module Two - Assessment Objectives: To describe important aspects of emergency evaluations of children and adolescents. Steps to Completion
Psychiatry for the Non-Psychiatrist. January 19, 2019
Psychiatry for the Non-Psychiatrist January 19, 2019 Overview A large percentage of patients visiting non-psychiatric practices suffer from psychiatric conditions alone or complicating medical, surgical
TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.
Brief Summary TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. SOURCE(S): Practice parameters for the assessment and treatment
7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is
Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: AZ.CP.PHAR.10.11.8 Effective Date: 07.2016 Last Review Date: 09.12.18 Line of Business: Arizona Medicaid Revision Log See Important Reminder at the end of this policy
Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand
The 25th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2014 Kota Kinabalu, Sabah, Malaysia 9th - 12th October, 2014 Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit
An Overview on the Use of Psychotropic Medications
An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers